Synthesis and biological activity of aza and deaza analogues of purine nucleosides

被引:0
作者
Matyugina, Elena S. [1 ]
Kochetkov, Sergey N. [1 ]
Khandazhinskaya, Anastasia L. [1 ]
机构
[1] Russian Acad Sci, Engelhardt Inst Mol Biol, Ul Vavilova 32, Moscow 119991, Russia
关键词
S-ADENOSYLHOMOCYSTEINE HYDROLASE; PHASE-TRANSFER GLYCOSYLATION; C-NUCLEOSIDES; ANTITUMOR-ACTIVITY; NUCLEIC-ACID; TRANSFER-RNA; STEREOSELECTIVE-SYNTHESIS; PRACTICAL SYNTHESIS; ANTIVIRAL ACTIVITY; GENERAL-SYNTHESIS;
D O I
10.1070/RCR5013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Analogues and derivatives of nucleic acid components have been used as key drugs in different areas of medicine over the past decades. The replacement of one or more nitrogen atoms of the heterocyclic base with a CH group affords deazapurine nucleoside analogues, and the replacement of the methine group with a nitrogen atom gives azapurine derivatives. A combination of aza and deaza moieties in the purine base leads to aza(deaza)-modified bases. Some nucleoside analogues were found to exhibit pronounced anticancer and antiviral activity. The synthesis and evaluation of biological activity of azaand deazapurine nucleoside analogues have attracted interest from researchers four decades ago. This review describes and integrates the studies concerning certain aspects of the synthesis and(or) activity of various representatives of this class of compounds. The structure-biological activity relationships are analyzed. The successful approaches to the design of azaand deazapurine nucleoside analogues are considered. A comparison is given for the methods of chemical and enzymatic synthesis of these compounds.
引用
收藏
页码:1454 / 1491
页数:39
相关论文
共 164 条
[1]   ENHANCEMENT OF BIOLOGICAL-ACTIVITY OF ADENOSINE-ANALOGS BY ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN [J].
ADAMSON, RH ;
ZAHAREVITZ, DW ;
JOHNS, DG .
PHARMACOLOGY, 1977, 15 (01) :84-89
[2]   Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease [J].
Agostini, Maria L. ;
Andres, Erica L. ;
Sims, Amy C. ;
Graham, Rachel L. ;
Sheahan, Timothy P. ;
Lu, Xiaotao ;
Smith, Everett Clinton ;
Case, James Brett ;
Feng, Joy Y. ;
Jordan, Robert ;
Ray, Adrian S. ;
Cihlar, Tomas ;
Siegel, Dustin ;
Mackman, Richard L. ;
Clarke, Michael O. ;
Baric, Ralph S. ;
Denison, Mark R. .
MBIO, 2018, 9 (02)
[3]   Structures of purine 2′-deoxyribosyltransferase, substrate complexes, and the ribosylated enzyme intermediate at 2.0 A resolution [J].
Anand, R ;
Kaminski, PA ;
Ealick, SE .
BIOCHEMISTRY, 2004, 43 (09) :2384-2393
[4]  
[Anonymous], 2013, Patent, Patent No. [2013084165A1, 2013084165]
[5]  
[Anonymous], 1989, Patent, Patent No. 9006312
[6]   SYNTHESIS OF 4-AMINO-1-BETA-D-RIBOFURANOSYL-1H-PYRROLO[2,3-B]PYRIDINE (1-DEAZATUBERCIDIN) AS A POTENTIAL ANTI-TUMOR AGENT [J].
ANTONINI, I ;
CLAUDI, F ;
CRISTALLI, G ;
FRANCHETTI, P ;
GRIFANTINI, M ;
MARTELLI, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) :1258-1261
[7]   DEAZA ANALOGS OF ADENOSINE AS INHIBITORS OF BLOOD-PLATELET AGGREGATION [J].
ANTONINI, I ;
CRISTALLI, G ;
FRANCHETTI, P ;
GRIFANTINI, M ;
MARTELLI, S ;
PETRELLI, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (03) :366-369
[8]   Methods for the synthesis of aza(deaza)xanthines as a basis of biologically active compounds [J].
Babkov, D. A. ;
Geisman, A. N. ;
Khandazhinskaya, A. L. ;
Novikov, M. S. .
RUSSIAN CHEMICAL REVIEWS, 2016, 85 (03) :308-334
[9]  
Bande O., 2014, EUR J ORG CHEM, V231
[10]  
BARASCUT JL, 1976, J CARB-NUCLEOS-NUCL, V3, P281